1. Casticin (Vitexicarpin) can significantly reduce vascular inflammation, through inhibition of ROS-NF-kappaB pathway in vascular endothelial cells. 2. Casticin may become a potential leading drug in the therapy of prostate carcinoma.
Molecular Weight:
374.34
Purity:
99.59%
CAS Number:
[479-91-4]
Formula:
C19H18O8
Target:
STAT
T6S1373
* VAT and and shipping costs not included. Errors and price changes excepted
